Silver Point Capital L.P. 13D and 13G filings for PDL BIOPHARMA INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-11 5:27 pm Purchase | 2020-12-30 | 13D | PDL BIOPHARMA INC PDLI | Silver Point Capital L.P. | 23,783,273 20.800% | 10,269,813 (+76.00%) | Filing |
| 2020-12-15 6:59 pm Purchase | 2020-12-10 | 13G | PDL BIOPHARMA INC PDLI | Silver Point Capital L.P. | 13,513,460 11.800% | 13,513,460 (New Position) | Filing |